Overexpression of LLT1 (CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A interaction

Keyphrases

• Natural Killer Cells 100%
• Overexpression 100%
• LLT1 100%
• Cell-mediated 100%
• Prostate Cancer Cells 100%
• C-type Lectin-like Receptor 2 100%
• Prostate Cancer 18%
• Inhibitory Receptors 18%
• Natural Killer Cell Activity 18%
• Cytolytic Activity 9%
• Cytotoxicity 9%
• Protein Level 9%
• MRNA Level 9%
• Surface Expression 9%
• Cancer Tissue 9%
• Lectin-like 9%
• Activating Receptors 9%
• Therapeutic Potential 9%
• First Line of Defence 9%
• New Therapeutics 9%
• Most Common Form 9%
• LNCaP 9%
• Normal Prostate 9%
• Cancer Causes 9%
• Cancer Mortality 9%
• Delicate Balance 9%
• Cancer Types 9%
• Natural Killer 9%
• Evade 9%
• 22Rv1 9%
• Prostate Cells 9%
• Prostate Cancer Cell Line DU145 9%
• Minimal Cell 9%
• Primary Prostate Cancer 9%
• Immune Attack 9%
• CD161 9%

Medicine and Dentistry

• Cancer Cell 100%
• Natural Killer Cell 100%
• Prostate Cancer 100%
• Malignant Neoplasm 37%
• Receptor 37%
• Infection 12%
• Cell Function 12%
• Cell Surface 12%
• Cytotoxicity 12%
• Cancer Tissue 12%
• Prostate Cancer Cell Line 12%
• Lectin 12%
• Artificial Cell 12%
• Target Cell 12%
• Prostate Cell 12%
• Cell Activation 12%
• Messenger RNA 12%

Immunology and Microbiology

• Natural Killer Cell 100%
• Cancer Cell 100%
• Cytotoxicity 12%
• Cell Surface 12%
• Cell Function 12%
• Target Cell 12%
• Lectin 12%
• Artificial Cell 12%
• Cell Activation 12%
• Prostate Cell 12%
• Prostate Cancer Cell Line 12%
• Cancer Tissue 12%
• Infection 12%